Tasting type 2 inflammation in the airways - 04/08/18
Doi : 10.1016/j.jaci.2018.06.009
Robert J. Snelgrove, PhD ⁎ 
, Clare M. Lloyd, PhD
, Clare M. Lloyd, PhD Inflammation Repair and Development, National Heart and Lung Institute, Imperial College London, London, United Kingdom
∗Corresponding author: Robert J. Snelgrove, PhD, Inflammation, Repair and Development Section, National Heart and Lung Institute, Imperial College London, South Kensington Campus, Level 3, Sir Alexander Fleming Building, London SW7 2AZ, United Kingdom.Inflammation, Repair and Development Section, National Heart and Lung InstituteImperial College LondonSouth Kensington CampusLevel 3, Sir Alexander Fleming BuildingLondonSW7 2AZUnited Kingdom
Key words : Type 2 immunity, type 2 innate lymphoid cells, tuft cells, epithelial cells, thymic stromal lymphopoietin, IL-25, chronic rhinosinusitis with nasal polyps, solitary chemosensory cell
Le texte complet de cet article est disponible en PDF.
| R.J.S. (209458/Z/17/Z) and C.M.L. (086718/Z/08/Z) are Wellcome Trust–funded Senior Research Fellows in Basic Biomedical Sciences. |
|
| Disclosure of potential conflict of interest: The authors declare that they have no relevant conflicts of interest. |
© 2018
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 142 - N° 2
P. 403-404 - août 2018 Retour au numéro
Article précédent
- TNF-?–induced protein 3 (A20): The immunological rheostat
- Asher Maroof, Dhavalkumar D. Patel
- Oral corticosteroids in preschool children with severe episodes of virus-associated wheeze: To treat or not to treat?
- Avraham Beigelman, Leonard B. Bacharier
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?